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(-)-Depudecin (1), isolated from the culture broths of the fungus Alternaria brassicicola 
[1], has been identified as a selective inhibitor of histone deacetylases (HDAC) with an 
IC50 in the low µM range. In contrast to representative HDAC inhibitors, depudecin 
represents a unique inhibitor of these enzymes by virtue of its molecular structure, 
featuring the presence of two oxirane rings separated by a trans double bond. 
Originally discovered as part of a biological screen directed towards the identification of 
antitumour agents with detransforming activity [2], depudecin was identified as a 
bioactive metabolite capable of reverting the transformed morphology of tumor cells. 
Depudecin induced cell cycle arrest and cellular differentiation [3], and also exhibited 
anti-angiogenesis activity [4]. Prompted by its striking biological properties and enticing 
structure, we decided to initiate a research program directed towards the synthesis of 
natural depudecin which has recently culminated with a linear total synthesis [5]. In 
order to develop an improved access to natural depudecin and analogues for further 
biological screenings, we explored a synthetic alternative as a shorter and more 
convergent approach. In this communication we report a new total synthesis of the 
natural product (-)-depudecin. A key feature of the synthesis is the utilization of an 
olefin cross-metathesis strategy, which provides for an efficient and improved access to 
natural depudecin. This strategy was applied to the preparation of the 10-epi and (+)-
depudecin, which represent interesting stereoisomeric analogues for SAR studies. 
 
 
 
 
 
 
Scheme 1. Structure of (-)-Depudecin and Olefin Cross-Metathesis Strategy. 
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